11654

    539524

    LALPATHLAB

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    DR. LAL PATH LABS LTD. Share Price Today

    DR. LAL PATH LABS LTD. is currently trading at ₹1746, up by ₹20.9 from the previous close. The stock touched an intraday high of ₹1752.00 and a low of ₹1717.40 during the latest trading session. Over the past one year, DR. LAL PATH LABS LTD. has delivered a return of 19.07%, while the stock has gained 6.75% in the last one month.

    DR. LAL PATH LABS LTD. performance

    Today’s low Today’s high
    ₹ 1717.40 ₹ 1752.00
    ₹ 1743.30
    52 week low 52 week high
    ₹ 1272.60 ₹ 1803.00
    ₹ 1743.30
    Open Price ₹ 1734.00
    Prev. Close ₹ 1725.10
    Volume (Shares) 107519.00
    Total traded value ₹ 1874.37
    Upper Circuit ₹ 2070.10
    Lower Circuit ₹ 1380.10
    info

    Investment Returns

    Over 1 Month 6.75% Over 3 Months 25.02% Over 6 Months 21.40% Over 1 Year 19.07%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    DR. LAL PATH LABS LTD. fundamentals


    • Market cap (Cr) 29,301.40
    • P/E Ratio (TTM) 56.94
    • Beta 0.49
    • Book Value / share 147.51
    • Return on equity 22.06%
    • EPS (TTM) 31.41
    • Dividend yield 1.19%
    • Net profit/quarter (Cr) 141.10
    info icon alternate text
    • Market cap (Cr) 29,231.00
    • P/E Ratio (TTM) 56.94
    • Beta 0.43
    • Book Value / share 147.51
    • Return on equity 22.06%
    • EPS (TTM) 31.41
    • Dividend yield 1.19%
    • Net profit/quarter (Cr) 141.10
    info icon alternate text

    DR. LAL PATH LABS LTD. Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 675.20
    Operating Expense 542.30
    Net Profit 141.10
    Net Profit Margin (%) 20.89
    Earnings Per Share (EPS) 8.45
    EBITDA 218.50
    Effective Tax Rate (%) 16.95
    Particulars DEC 2025 (Values in Cr)
    Revenue 632.10
    Operating Expense 505.50
    Net Profit 92.10
    Net Profit Margin (%) 14.57
    Earnings Per Share (EPS) 5.52
    EBITDA 170.20
    Effective Tax Rate (%) 25.18
    Particulars SEP 2025 (Values in Cr)
    Revenue 699.60
    Operating Expense 527.60
    Net Profit 145.70
    Net Profit Margin (%) 20.82
    Earnings Per Share (EPS) 17.46
    EBITDA 237.90
    Effective Tax Rate (%) 25.20
    Particulars JUN 2025 (Values in Cr)
    Revenue 640.70
    Operating Expense 494.60
    Net Profit 129.30
    Net Profit Margin (%) 20.18
    Earnings Per Share (EPS) 15.51
    EBITDA 209.70
    Effective Tax Rate (%) 25.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 577.20
    Operating Expense 457.50
    Net Profit 148.40
    Net Profit Margin (%) 25.71
    Earnings Per Share (EPS) 17.80
    EBITDA 184.30
    Effective Tax Rate (%) -2.41
    Particulars MAR 2026 (Values in Cr)
    Revenue 2647.60
    Operating Expense 2070.00
    Net Profit 508.20
    Net Profit Margin (%) 19.19
    Earnings Per Share (EPS) 30.45
    EBITDA 836.30
    Effective Tax Rate (%) 23.02
    Particulars MAR 2025 (Values in Cr)
    Revenue 2351.60
    Operating Expense 1841.80
    Net Profit 497.30
    Net Profit Margin (%) 21.14
    Earnings Per Share (EPS) 59.70
    EBITDA 777.00
    Effective Tax Rate (%) 19.95
    Particulars MAR 2024 (Values in Cr)
    Revenue 2125.10
    Operating Expense 1708.89
    Net Profit 346.70
    Net Profit Margin (%) 16.31
    Earnings Per Share (EPS) 41.72
    EBITDA 646.90
    Effective Tax Rate (%) 28.14
    Particulars MAR 2023 (Values in Cr)
    Revenue 1769.00
    Operating Expense 1424.80
    Net Profit 292.40
    Net Profit Margin (%) 16.52
    Earnings Per Share (EPS) 35.28
    EBITDA 507.29
    Effective Tax Rate (%) 25.17
    Particulars MAR 2022 (Values in Cr)
    Revenue 1878.80
    Operating Expense 1470.89
    Net Profit 345.30
    Net Profit Margin (%) 18.37
    Earnings Per Share (EPS) 41.61
    EBITDA 565.50
    Effective Tax Rate (%) 25.09
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 149.69
    ROE % 21.78
    ROCE % 27.45
    Total Debt to Total Equity 0.08
    EBITDA Margin 30.90
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 259.92
    ROE % 24.48
    ROCE % 29.22
    Total Debt to Total Equity 0.10
    EBITDA Margin 32.06
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 221.53
    ROE % 20.61
    ROCE % 25.57
    Total Debt to Total Equity 0.19
    EBITDA Margin 30.47
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 199.87
    ROE % 15.22
    ROCE % 18.51
    Total Debt to Total Equity 0.30
    EBITDA Margin 26.36
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 180.17
    ROE % 25.51
    ROCE % 29.46
    Total Debt to Total Equity 0.25
    EBITDA Margin 29.38
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 147.58
    ROE % 22.06
    ROCE % 27.56
    Total Debt to Total Equity 0.07
    EBITDA Margin 31.59
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 255.32
    ROE % 25.27
    ROCE % 29.72
    Total Debt to Total Equity 0.07
    EBITDA Margin 33.04
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 215.71
    ROE % 19.87
    ROCE % 24.77
    Total Debt to Total Equity 0.12
    EBITDA Margin 30.44
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 202.70
    ROE % 18.49
    ROCE % 20.93
    Total Debt to Total Equity 0.21
    EBITDA Margin 28.68
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 176.63
    ROE % 25.68
    ROCE % 29.69
    Total Debt to Total Equity 0.14
    EBITDA Margin 30.10
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 909.53
    Total Assets 3145.99
    Total Liabilities 3145.99
    Total Equity 2541.28
    Share Outstanding 16
    Price to Book Ratio 8.90
    Return on Assets (%) 16.04
    Return on Capital (%) 19.86
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 838.67
    Total Assets 2716.78
    Total Liabilities 2716.78
    Total Equity 2206.47
    Share Outstanding 8
    Price to Book Ratio 9.71
    Return on Assets (%) 17.93
    Return on Capital (%) 22.08
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 830.31
    Total Assets 2455.96
    Total Liabilities 2455.96
    Total Equity 1885.36
    Share Outstanding 8
    Price to Book Ratio 10.49
    Return on Assets (%) 14.56
    Return on Capital (%) 18.17
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 665.41
    Total Assets 2385.56
    Total Liabilities 2385.56
    Total Equity 1699.54
    Share Outstanding 8
    Price to Book Ratio 9.02
    Return on Assets (%) 10.01
    Return on Capital (%) 12.34
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 617.59
    Total Assets 2353.22
    Total Liabilities 2353.22
    Total Equity 1543.53
    Share Outstanding 8
    Price to Book Ratio 14.76
    Return on Assets (%) 14.65
    Return on Capital (%) 18.25
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 843.81
    Total Assets 3049.15
    Total Liabilities 3049.15
    Total Equity 2472.83
    Share Outstanding 16
    Price to Book Ratio 8.90
    Return on Assets (%) 16.66
    Return on Capital (%) 20.55
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 767.53
    Total Assets 2620.95
    Total Liabilities 2620.95
    Total Equity 2134.23
    Share Outstanding 8
    Price to Book Ratio 9.71
    Return on Assets (%) 18.97
    Return on Capital (%) 23.3
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 751.67
    Total Assets 2349.16
    Total Liabilities 2349.16
    Total Equity 1800.72
    Share Outstanding 8
    Price to Book Ratio 10.49
    Return on Assets (%) 14.75
    Return on Capital (%) 18.4
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 534.21
    Total Assets 2320.17
    Total Liabilities 2320.17
    Total Equity 1689.86
    Share Outstanding 8
    Price to Book Ratio 9.02
    Return on Assets (%) 12.60
    Return on Capital (%) 15.18
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 542.90
    Total Assets 2210.78
    Total Liabilities 2210.78
    Total Equity 1472.11
    Share Outstanding 8
    Price to Book Ratio 14.76
    Return on Assets (%) 15.61
    Return on Capital (%) 19
    Particulars MAR 2026 (Values in Cr)
    Net Income 509.75
    Cash from Operations 810.99
    Cash from Investing -421.86
    Cash from Financing -263.57
    Net change in Cash -49.82
    Free Cash Flow 978.01
    Particulars MAR 2025 (Values in Cr)
    Net Income 492.25
    Cash from Operations 732.78
    Cash from Investing -303.16
    Cash from Financing -334.02
    Net change in Cash -68.30
    Free Cash Flow 777.07
    Particulars MAR 2024 (Values in Cr)
    Net Income 362.29
    Cash from Operations 667.36
    Cash from Investing -24.26
    Cash from Financing -413.86
    Net change in Cash 97.20
    Free Cash Flow 718.53
    Particulars MAR 2023 (Values in Cr)
    Net Income 241.07
    Cash from Operations 562.46
    Cash from Investing -287.30
    Cash from Financing -283.18
    Net change in Cash -114.46
    Free Cash Flow 598.97
    Particulars MAR 2022 (Values in Cr)
    Net Income 350.29
    Cash from Operations 576.72
    Cash from Investing -449.24
    Cash from Financing 136.45
    Net change in Cash 133.89
    Free Cash Flow 670.82
    Particulars MAR 2026 (Values in Cr)
    Net Income 508.20
    Cash from Operations 772.48
    Cash from Investing -382.09
    Cash from Financing -255.94
    Net change in Cash -32.16
    Free Cash Flow 936.85
    Particulars MAR 2025 (Values in Cr)
    Net Income 497.26
    Cash from Operations 694.63
    Cash from Investing -292.99
    Cash from Financing -324.74
    Net change in Cash -77.74
    Free Cash Flow 737.94
    Particulars MAR 2024 (Values in Cr)
    Net Income 346.73
    Cash from Operations 632.42
    Cash from Investing 1.16
    Cash from Financing -410.53
    Net change in Cash 95.23
    Free Cash Flow 679.51
    Particulars MAR 2023 (Values in Cr)
    Net Income 292.35
    Cash from Operations 526.65
    Cash from Investing -288.47
    Cash from Financing -270.04
    Net change in Cash -130.98
    Free Cash Flow 558.36
    Particulars MAR 2022 (Values in Cr)
    Net Income 345.25
    Cash from Operations 543.25
    Cash from Investing -448.53
    Cash from Financing 141.24
    Net change in Cash 118.43
    Free Cash Flow 606.34
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTERPRISE LT 8777.65 64.52 13.32 126209.14 6680.00 8948.10
    FORTIS MALAR HOSPITALS LIMITED 50.46 22.83 2.75 94.57 40.75 76.00
    SHREE PACETRONIX LTD. 152.70 18.22 3.21 57.26 71.00 283.15
    TRANSGENE BIOTEK LTD. 3.07 0.00 2.77 23.26 1.83 5.26
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTERPRISE LT 8777.65 84.07 12.66 126209.14 6680.00 8948.10
    [-] 0.0 0.0 0.0 0.0 0.0 0.0
    CHENNAI MEENAKSHI MULTISPECIAL 39.15 0.00 -9.52 29.25 30.30 57.48
    KOVAI MEDICAL CENTER & HO 5998.00 26.84 4.97 6561.81 5010.00 6725.00

    DR. LAL PATH LABS LTD. shareholding pattern

    Holding
    8.22%
    53.21%
    17.18%
    21.38%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    DR. LAL PATH LABS LTD. Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    1747.90 1.32 redarrow
    red-green-graph indicator
    0 Bearish
    16 Bullish
    • 5 Days 1693.00
    • 26 Days 1647.70
    • 10 Days 1678.10
    • 50 Days 1605.60
    • 12 Days 1673.70
    • 100 Days 1550.90
    • 20 Days 1658.40
    • 200 Days 1519.60
    1711.87 PIVOT
    First Support 1685.73 First Resistance 1751.23 Second Support 1646.37 Second Resistance 1777.37 Third Support 1620.23 Third Resistance 1816.73
    RSI 64.29 ADX 28.42 MACD 26.01 Williams % R -10.09 Commodity Channel Index (CCI) 177.05
    Date 2026-07-13 Week 255929.00 Same Day 181871.00 Month 239703.00
    1 Year 0.50 3 Year 0.49
    Over 1 Month
    6.75% down
    Over 1 Year
    19.07% down
    Over 3 Months
    25.02% down
    Over 3 Years
    13.57% down
    Over 6 Months
    21.40% down
    Over 5 Years
    0.02% down

    DR. LAL PATH LABS LTD. Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    25 Jun 2026 4.0 Final 26 Jun 2026 Equity shares
    05 Feb 2026 3.5 Interim 3 05 Feb 2026 Equity shares
    07 Nov 2025 7.0 Interim 2 07 Nov 2025 Equity shares
    06 Aug 2025 6.0 Interim 06 Aug 2025 Equity shares
    06 Jun 2025 6.0 Final 06 Jun 2025 Equity shares
    05 Feb 2025 6.0 Interim 3 05 Feb 2025 Equity shares
    05 Nov 2024 6.0 Interim 2 05 Nov 2024 Equity shares
    20 Aug 2024 6.0 Interim 20 Aug 2024 Equity shares
    10 Jun 2024 6.0 Final 10 Jun 2024 Equity shares
    13 Feb 2024 12.0 Interim 2 13 Feb 2024 Equity shares
    11 Aug 2023 6.0 Interim 11 Aug 2023 Equity shares
    11 Aug 2023 6.0 Final 11 Aug 2023 Equity shares
    05 Aug 2022 6.0 Interim 09 Aug 2022 Equity shares
    22 Jun 2022 6.0 Final 23 Jun 2022 Equity shares
    18 Aug 2021 6.0 Interim 22 Aug 2021 Equity shares
    20 Jul 2021 8.0 Final 22 Jul 2021 Equity shares
    09 Feb 2021 6.0 Interim 2 10 Feb 2021 Equity shares
    18 Nov 2020 6.0 Interim 19 Nov 2020 Equity shares
    05 Mar 2020 6.0 Interim 2 06 Mar 2020 Equity shares
    20 Nov 2019 6.0 Interim 21 Nov 2019 Equity shares
    02 Aug 2019 3.5 Final 06 Aug 2019 Equity shares
    19 Nov 2018 2.5 Interim 20 Nov 2018 Equity shares
    03 Aug 2018 3.0 Final 07 Aug 2018 Equity shares
    20 Nov 2017 1.5 Interim 21 Nov 2017 Equity shares
    12 Jul 2017 1.7 Final 14 Jul 2017 Equity shares
    13 Feb 2017 1.3 Interim 14 Feb 2017 Equity shares
    20 Jul 2016 2.45 Final 22 Jul 2016 Equity shares
    Ex-Date Ex-Bonus Ratio
    19 Dec 2025 19 Dec 2025 1:1
    Dividend date Dividend amount Dividend type Record date Instrument type
    25 Jun 2026 4.0 Final 26 Jun 2026 Equity shares
    05 Feb 2026 3.5 Interim 3 05 Feb 2026 Equity shares
    07 Nov 2025 7.0 Interim 2 07 Nov 2025 Equity shares
    06 Aug 2025 6.0 Interim 06 Aug 2025 Equity shares
    06 Jun 2025 6.0 Final 06 Jun 2025 Equity shares
    05 Feb 2025 6.0 Interim 3 05 Feb 2025 Equity shares
    05 Nov 2024 6.0 Interim 2 05 Nov 2024 Equity shares
    20 Aug 2024 6.0 Interim 20 Aug 2024 Equity shares
    10 Jun 2024 6.0 Final 10 Jun 2024 Equity shares
    13 Feb 2024 12.0 Interim 2 13 Feb 2024 Equity shares
    11 Aug 2023 6.0 Interim 11 Aug 2023 Equity shares
    11 Aug 2023 6.0 Final 11 Aug 2023 Equity shares
    05 Aug 2022 6.0 Interim 09 Aug 2022 Equity shares
    22 Jun 2022 6.0 Final 23 Jun 2022 Equity shares
    18 Aug 2021 6.0 Interim 22 Aug 2021 Equity shares
    20 Jul 2021 8.0 Final 22 Jul 2021 Equity shares
    09 Feb 2021 6.0 Interim 2 10 Feb 2021 Equity shares
    18 Nov 2020 6.0 Interim 19 Nov 2020 Equity shares
    05 Mar 2020 6.0 Interim 2 06 Mar 2020 Equity shares
    20 Nov 2019 6.0 Interim 21 Nov 2019 Equity shares
    02 Aug 2019 3.5 Final 06 Aug 2019 Equity shares
    19 Nov 2018 2.5 Interim 20 Nov 2018 Equity shares
    03 Aug 2018 3.0 Final 07 Aug 2018 Equity shares
    20 Nov 2017 1.5 Interim 21 Nov 2017 Equity shares
    12 Jul 2017 1.7 Final 14 Jul 2017 Equity shares
    13 Feb 2017 1.3 Interim 14 Feb 2017 Equity shares
    20 Jul 2016 2.45 Final 22 Jul 2016 Equity shares
    Ex-Date Ex-Bonus Ratio
    19 Dec 2025 19 Dec 2025 1:1

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Dr Lal Pathlabs Ltd?

    Answer Field

    Dr Lal Pathlabs Ltd share price is for NSE ₹ 1,746.00 & for BSE ₹ 1,743.75 as on Jul 14 2026 02:07 PM.

    What is the Market Cap of Dr Lal Pathlabs Ltd Share?

    Answer Field

    The market cap of Dr Lal Pathlabs Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 14 2026 02:07 PM.

    What is the 52 Week High and Low of Dr Lal Pathlabs Ltd?

    Answer Field

    The 52 Week High and Low of Dr Lal Pathlabs Ltd for NSE is ₹ 1,803.00 and ₹ 1,272.60 and for BSE is ₹ 1,803.60 and ₹ 1,272.00.

    What is 1 year return for Dr Lal Pathlabs Ltd?

    Answer Field

    The 1 year returns on the stock has been 19.07%.

    What is the P/E Ratio of Dr Lal Pathlabs Ltd Share?

    Answer Field

    As on Jul 14 2026 02:07 PM the price-to-earnings (PE) ratio for Dr Lal Pathlabs Ltd share is 56.94.

    What is the PB ratio of Dr Lal Pathlabs Ltd Share?

    Answer Field

    As on Jul 14 2026 02:07 PM, the price-to-book (PB) ratio for Dr Lal Pathlabs Ltd share is 147.51.

    How to Buy Dr Lal Pathlabs Ltd Share?

    Answer Field

    You can trade in Dr Lal Pathlabs Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Dr Lal Pathlabs Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Dr Lal Pathlabs Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Dr Lal Pathlabs Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |